Diagnosis of Duchenne dystrophy by enhanced detection of small mutations

Neurology

Volumn 57, Issue 4, 2001, Pages 645-650

  Mendell, Jerry R ^b,c   Buzin, C H ^a   Feng, J ^a   Yan, J ^a   Serrano, C ^b   Sangani, D S ^b   Wall, C ^b   Prior, T W ^b   Sommer, S S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ADOLESCENT; ARTICLE; BASE PAIRING; CHILD; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA DETERMINATION; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUSCLE BIOPSY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; X CHROMOSOME RECESSIVE DISORDER;

EID: 0035964228     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.645     Document Type: Article

References (54)

1. Genetics of Duchenne muscular dystrophy
2. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
3. Characterization of dystrophin in muscle-biopsy specimens from Duchenne's and Becker's muscular dystrophy patients
4. Molecular and phenotype analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene
5. Malignant hyperpyrexia and Duchenne muscular dystrophy: A case report
6. Malignant hyperthermia in a child with Duchenne muscular dystrophy
7. Malignant hyperthermia susceptibility in X-linked muscle dystrophies
8. Malignant hyperthermia in Duchenne muscular dystrophy
9. Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types
10. The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion
11. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications
12. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies
13. Molecular genetic analysis of 67 patients with Duchenne/Becker muscular dystrophy
14. Dystrophin gene analysis on 130 patients with Duchenne muscular dystrophy with a special reference to muscle mRNA analysis
15. Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: From Southern blot to protein truncation test
16. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification
17. Duplicational mutation at the Duchenne muscular dystrophy locus: Its frequency, distribution, origin, and phenotype genotype correlation
18. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR
19. Point mutation at the carboxy terminus of the human dystrophin gene: Implications for an association with mental retardation in Duchenne muscular dystrophy patients
20. Searching for the 1 in 2,400,000: A review of dystrophin gene point mutations
21. Spectrum of small mutations in the dystrophin coding region
22. Point mutation screening for 16 exons of dystrophin by multiplex single-strand conformation polymorphism analysis
23. Novel mutations and polymorphisms in the human dystrophin gene detected by double-strand conformation analysis
24. Novel point mutations in the dystrophin gene
25. Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations
26. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test
27. The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: An updated protocol
28. Dystrophin point mutation screening using a multiplexed protein truncation test
29. Identification of three novel mutations in the dystrophin gene detected by the heteroduplex/SSCA screening procedure. Mutations in brief no. 222
30. Detection of virtually all mutations-SSCP (DOVAM-S): A rapid method for mutation scanning with virtually 100% sensitivity
31. Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: Evidence that the scanning conditions are generic
32. Clinical investigation in Duchenne dystrophy: 2. Determination of the 'power' of therapeutic trials based on the natural history
33. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction
34. Multiplex PCR for identifying dystrophin gene deletions
35. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
36. Recommendations for a nomenclature system for human gene mutations
37. Exon structure of the human dystrophin gene
38. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy
39. Weekly clinicopathological exercises. Case 22-1998. A 22-year-old man with a cardiac transplant and creatine kinase elevation
40. Molecular genetic aspects of cardiomyopathy
41. Mutation in the dystrophin gene selectively affecting dystrophin expression in the heart
42. X-linked dilated cardiomyopathy and the dystrophin gene
43. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family
44. Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations
45. The nature and mechanism of human gene mutation
46. New variant von Willebrand disease with defective binding to factor VIII
47. Calf myopathy with a twist
48. Dystrophinopathy in isolated cases of myopathy in females
49. Genetic counseling of isolated carriers of Duchenne muscular dystrophy
50. Asymptomatic dystrophinopathy
51. Dystrophinopathy in two young boys with exercise-induced cramps and myoglobinuria
52. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies
53. Clinical variability in Becker muscular dystrophy: Genetic, biochemical and immunohistochemical correlates